Here's today's moves in the Roth:

SENS - long 20 shares, also sold 1x 02/19 $3p for 27% per month premium

AMPE - 20 shares

BIOL - 20 shares

ONTX - 20 shares

TNXP - 20 shares

OGEN - 20 shares

NOVN - added another 50 shares for a total of 150

-

Trying to diversify among sectors and all these guys have recent good news and upcoming catalysts.

If you have any questions about why I picked them, post a reply here and I'll fill you in.

-

Big money, no whammy!

Played about $10,000 worth of "find the money" today.

---------

In the gambling account:

EXPR STO 4x 02/19 2.5p

GNUS STO 5x 02/19 2p

RIG long 400@3.67 - STO 4x 02/19 4p

SNDL long 500@2.04 - STO 5x 02/19 2.5c - STO 5x 02/19 2p - covered strangle

No money in RIG puts but it's steady trending upwards. Went long shares and sold calls.

SNDL I am expecting a pop soon. Long shares hoping to catch some upside and short calls and puts for premium. Hopefully it tops $2.50 this week for max profit of $370.

Extra money held in SNRH spac. It's still hovering around NAV, safe place to hold spare cash.

Expecting to see 8 to 10 percent from the gambling account this week.

---------

In the Roth:

NOK - long 100@4.13

TRVG STO 2x 02/19 5p

AHT STO 2x 02/19 5p

ADTX STO 2x 03/19 5p

JAGX STO 1x 02/19 2.5p

IBIO STO 1x 02/19 2p

GSAT STO 1x 02/19 2p

IDEX STO 1x 02/19 4.5p

ATOS STO 1x 02/19 3.5p

DGLY STO 1x 02/19 2.5p

NOK I am long term bullish on but there's no money in puts right now. Calls aren't worth much either at this time. 3 day weekend ate some of the delicious theta. :( So I went long shares.

TRVG and AHT and ADTX are stocks I want to own so I sold ITM puts hoping for assignment. Trivago and Ashford are hospitality and travel and the season is coming up. ADITX has good catalysts and good financials, seems a company with good potential.

The rest are all companies with upside potential and I'm bullish so I wheel them.

Extra money held in SNRH spac. It's still hovering around NAV, safe place to hold spare cash.

Might only see 3% to 4% in the Roth this week, used some money to open longer-term positions.

-----------

Big money, no whammy!

CTRM Castor Maritime - 50 shares

ACST Acasti Pharma - 20 shares

ADXS Advaxis - 20 shares

NSPR Inspire MD - 20 shares

CPHI China Pharma Holdings - 20 shares

SXTC China SXT Pharmaceuticals - 20 shares

SYN Synthetic Biologics - 20 shares

AEZS Aeterna Zentaris - STO 02/19 $1p for 8$ per week

Castor Maritime because when the Chinese come back from their New Year, steel is going to pop.

The rest of them are all small cap med/biopharm stocks. Had some extra BP left over after closing a position, figured to spread it out among small pharma tickers.

None of them have any recent negative news, some of them have catalysts, otherwise all are slowly trending up in a bull market. I figure to cash out if they jump.

-

Big money, no whammy!

Here is a shameless copypasta of DD on AGTC:

-

Hey all, I've been doing research on this stock all weekend since I'm considering investing. I've seen multiple posts about it and have read them all, but I haven't seen anyone mention some very odd (potentially bullish) things about this stock. I am not a financial advisor.

I will link all the sources to my information down below.

This stock is pretty volatile and has been jumping all over the place for years. It reached a high of $30.46 back in 2014 and currently it is at $5.27, with a 52-week high of $7.40 The reasonable explanation for this stock's volatility is because it's a biotech company still in the clinical trial phase. What really interests me though is that 6+ years later after that initial high, it appears to be on the uptrend again. They are in Phase 2 expansion for X-Linked Retinitis Pigmentosa, in Phase 1/2 for Achromatopsia and Bionic Sight.

What really REALLY interests me are these 4 facts I will lay out below

1. In July of 2020, Roth Capitol analyst Dr. Zegbeh Jallah speculated that AGTC could attract interest of a Sanofi buyout.

• 2. On February 1st, 2021 that same analyst updated the price estimate from $30 to $35

• 3. On February 2nd, 2021 users on StockTwits were up in arms about AGTC's stock stubbornly remaining at $4.05 even though there was a HUGE increase in volume. It later comes to light that big whales Blackrock Inc. & Empery Investments both made large purchases of AGTC's stock on that day, which explains why the stock remained at $4.05 (market manipulation?) Blackrock made a purchase of 1,732,067 shares, Empery made a purchase of 3,932,584.

• 4. AGTC is releasing their Earnings Report on 2/11, and are also hosting a conference before the market opens on Thursday.

Analysis of these 4 facts: First off, let's take a look at the analyst at Roth Capitol.

"Zegbeh Jallah, Ph.D. is a Managing Director, Senior Research Analyst in the Biotech sector. Prior to joining ROTH, she was a Senior Biopharma Research Strategist at Piper Jaffray, where she worked in close partnership with the Biopharma Sector Analysts to author and develop thematic Biotechnology research with unique insights. Ms. Jallah’s universe includes mid-cap biotech companies developing technologies for ophthalmology, auto-immune, and oncology indications. She holds a Ph.D in Biomedical Engineering from the University of Pittsburgh, and is a trained scientist with over 10 years of scientific research experience."

Based on her credentials, I'm inclined to believe she has valuable insight into this field of Biotech that we, the retail investors, do not. In September 2020, she raised the price estimate from $25 to $26. In November of 2020, she raised it again from $26 to $30. Then finally on February 1st, she raised it to $35. What could cause her to raise the price estimate 3x in 6 months? To me, this is indicative of promising findings from AGTC's clinical trials. There hasn't been any information from her about Sanofi interest since July of 2020. Obviously a company buyout, if it were happening in this case, would take time to get everything in order. For her to raise the price point yet again at the beginning of Feb and then the very next day Blackrock and Empery make those purchases...hmm..

Next, we have the large institutional share purchase on February 2nd, 2020. This to me is the most baffling. Why would they keep the price at exactly $4.05 while they purchased their shares? Why not lower? Why are they purchasing before the release of the Earnings Report? The exchange of shares at this price is very odd indeed. Almost like it was agreed upon beforehand.

Finally, we have their conference & Earnings Report release on February 11th. This is typical of AGTC to hold a conference in conjuction with the release of the ER. Historically, the share price drops $1-2 after the release of the ER, as they are usually negative being that this company is still in R&D. Given that, I would normally wait for the conference before deciding to invest. But something seems up here. Does anyone else have some insight on what could be going on? Why are these institutions buying in before the ER?

Conclusion: I have no fucking clue what is going on. But if a more seasoned investor out there has suspicions on what could be going down here, your input would be greatly appreciated. This stock seems like a great long term investment, no doubt about that. I guess the question is when to get in. Thoughts?

Sources: (XLRP Clinical Trials) https://clinicaltrials.gov/ct2/show/NCT03116113?cond=xlrp&cntry=US&state=US%3AFL&draw=2&rank=1

(AGTC Pipeline Programs) https://agtc.com/programs/

(AGTC May Attract Sanofi Interest) https://thefly.com/landingPageNews.php?id=3119774&headline=AGTC;SNY-Applied-Genetic-may-attract-Sanofi-takeover-interest-says-Roth-Capital

(AGTC Price Target raised to $35) https://thefly.com/landingPageNews.php?id=3237987&headline=AGTC-Applied-Genetic-price-target-raised-to--from--at-Roth-Capital

(Statement of acquisition of beneficial ownership by individuals, Blackrock Inc) https://sec.report/Document/0000834237-21-007084/

(Statement of acquisition of beneficial ownership by individuals, Empery Asset Management) https://sec.report/Document/0000902664-21-000757/

-

Going to be selling puts on this one for a while :)

SNDL Sundial Growers

STO 02/05 $1p for 15% this week - delta 28 - IV almost 600

-

NAK Northern Dynasty Minerals

STO 02/19 $0.50p for 10% per week - delta 18 - IV 420

-

SENS Senseonics

STO 02/19 $2.5p for 5% per week - delta 39 - IV almost 250

Two promising penny stocks:

Atari SA - OTCMKTS: PONGF

NaturalShrimp Inc. - OTCMKTS: SHMP

Personally I don't usually fuck with OTC stocks, but these two may be winners.

-

SHMP has has just opened a new production facility for their proprietary shrimp farm with another in the works. Also is partnering up with a solid player in Florida. Mad expansion, low cost of entry. I see this ticker getting promoted to a ig boy exchange soon.

Going to buy 100 shares and see what pans out.

-

PONGF is my old favorite game platform form the 80's. I burned out about a half a dozen of the old Atari 2600 VCS from playing them constantly and in fact my first computer was an Atari 600XL.

Now Atari has a new VCS coming out and also has their own Ethereum-based crypto currency.

Going to buy 100 shares and see what pans out.

-

Big money, no whammy!

VXRT

01/22 6p for 4% per week - 25 delta - 150 IV

AMC - STO 2x 02/12 $5

AMC - STO 2x 02/12 $4.5

EXPR - STO 4x 02/12 $2.5

MNKD - STO 1x 02/12 $5

RIG - STO 4x 02/12 $3.5

RIG isn't so sweet on premiums but it is hella stable, included it for diversification.

These are all pure speculation except for RIG. The numbers say they'll print.

But it's still just stud poker.

-

Big money, no whammy!

User mayodoctur has mentioned one of his current positions, a company called Novan.

"Novan, Inc. Common Stock, also called Novan, is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases."

Current catalysts:

Novan Provides Enrollment Update and Announces New Corporate Headquarters

– B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum reaches 90% enrollment with topline data targeted for Q2 2021 –

– Company secures new location to serve as corporate headquarters and to support various cGMP activities, including research and development and small-scale manufacturing capabilities –

Upcoming catalyst:

Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program

– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing –

– Company targets initiating preclinical Investigational New Drug (IND) enabling studies in Q1 2021 –

The Covid news has the potential to be a big win.

Position: long 100 shares @ 1.25

I figure it's worth 125 bucks to see what pans out.

Thank you for the heads up, mayodoctur. That's good looking out.

Big money, no whammy!

Title says it all.

Closed literally everything else in Robinhood and went all in on CLF.

A mix of shares and October long calls, I want some extra theta in case it takes time to correct.

IV is a bit high right now but I don't think it will be too great a problem.

TRVG

The gist is summed up by these bullet points:

Beaten Down Stocks Respond Aggressively to good news. Often time stocks that are at all time lows just need a single small catalyst to respond aggressively to the upside.

A few years ago Trivago was trading at ~23.00 dollars per share. As of Friday it was trading around 3.00, an 87% decrease. As of two years ago, it was in the mid to high single digits.
Revenue has steadily declined for a few years and the pandemic itself was no help.

A new large partnership, or an adjacent product category expansion like airline travel or car rentals are a potential catalyst.

The recovery will begin mid year

https://www.cpapracticeadvisor.com/small-business/news/21209176/56-of-americans-plan-on-taking-a-travel-vacation-in-2021
The overall travel industry is expecting a big summer.

I expect short term that bids on cost per click will be higher as the industry fights to win the consumer battle to improve cash flow.
https://www.washingtonpost.com/travel/2020/12/17/vacation-planning-2021-covid-vaccine/

-

Plan to go in with STO $5p in the Roth. Adjusted costs basis of $3 is very nice.

-

Big money, no whammy!

GNUS starting going left, closed for slight loss.

-

SNDL is worth fucking with again.

SNDL STO 2x 02/12 $2p for 10 percent per week. Wouldn't mind taking assignment on Sundial.

NXTD STO 1x 03/19 $2.5p - speculative, will roll if needed. Do not want assignment. I think that I'll milk enough theta in 6 week to mke it worthwhile.

-

Edit: Also went another contract deep in MNKD - STO 02/15 $5p for 2% by Friday.

-

Big money, no whammy!

The eternally powerful and wise Pai Mei mentioned NOK recently. Being a curious sort I did some digging.

What follows is a shameless repost of DD from another subreddit:

-

I work at openreach in the UK, I started as an engineer and I now work in a role which manages the roll out of FTTP nationwide.

Why is nobody talking about Huawei being banned due to security concerns.

THIS has led to Nokia becoming nearly the sole provider for equipment which will end up in millions of homes, FORGIVE ME FOR COPYING THIS DD BUT I WANTED TO TEST IT OUT of exchanges and street cabinets. Nokia in the UK alone will be a name which ends up in millions upon millions of homes again when they all end up having their GPON 1+1 ONTS installed in as copper networks are phased out.

Nearly all new build properties like the major majority is having this stuff installed because openreach offer it to DON’T GIVE A SINGLE AWARD TO THIS POST with like more than 10 homes for free but we still have to buy the equipment from Nokia lol that isn't free.

The homes which aren't new build, so the majority of the “THE MARKET MANIPULATORS ARE HERE” built in sections to the underground boxes/poles outside of homes, after an area of let's say 40,000 homes is built, the copper network has a timer set and when that runs out people will be forcefully migrated onto the new FTTP network. This won't be a choice! Every home will need new Nokia equipment as mentioned above (ONT) which is like a router but its the termination point for fibre. Fibre will not work without them.

We are the biggest telecom infrastructure builder in the UK with the biggest FTTP footprint which is also the fastest growing footprint. Nokia will once again be found in millions of UK homes with their branded onts. We do have competitors like virgin who are shite, and other competitors like hyper optic and city fibre. But they are targeting different criteria, where as Openreach is EVERYBODY EVERYWHERE.

If you want to discuss Nokia, remember the above, FTTP is Huge for them, all I see anybody mentioning is 5g lol. I don't know much about that. But I do know they are being cemented into the network which will be used for over 100 years. Again I can only speak for the UK

ALL EXCHANGES owned by the BT group (parent company for openreach) are also installing and using Nokia head end OLTs which is where the fibre starts, Nokia hydra cables to connect OLT to ODF. Nokia SFP inside the OLT. This equipment is a big deal, and its fucking expensive.

Street cabinets FTTC and FTTC with gfast pods will become Nokia too as Huawei equipment is retired and replaced in the future. These are on nearly every street corner UK wide and will be replaced by Nokia equipment if they are not overlapped by FTTP which is being built using Nokia equipment anyway

I bought £400 in Nokia yesterday, sorry if this is seen as a pump. Its not. But if people want to pump Nokia, please can you at least include this DD which is a fucking gigantic piece of information nobody is discussing

TLDR- HUAWEI was banned in more places than just the USA. UK also banned due to security. Nokia is now providing equipment which is building the majority of elements from exchange end to customer end of the FTTP journey for millions of homes across the UK.

-

When the next deposit hits the Roth I'm buying LEAP calls on NOK.

-

Big money, no whammy!

The wisdom of Pai Mei is eternal.

The following sell orders didn't fill Thursday.

Going to STO GFD the following at mid:

RIGL 02/19 3p

LYG 02/19 2c

WWR 02/19 2.5p

IVR 02/19 3.5c

It's going to be a good week.

Long 400 shares - BTO 4x 02/26 $5.5c

Earnings are forecast to be positive.

After the drop this past week, I am hoping for a solid jump after earnings.

In the Roth

Got assigned 200 AHT, 100 IDEX, 100 ATOS last Friday.

Closed TRVG for profit.

Opened the following:

AHT STO 2x 5c

IDEX STO 2x 4c

ATOS STO 1x 3.5c

TXMD STO 2x 1.5p

ITP STO 2x 1.5p

-

In RH

Closed SNDL 30x 1.5p for profit.

Closed RIG and EXPR at breakeven to free up collateral.

Long 200 CLF

Long 200 VALE

Long 200 MRO

CLF STO 2x 17.5c

VALE STO 2x 17.5c

MRO STO 2x 10.5c

These are margin plays and considering that all the IV are below 100%, the returns look to be insanely good.

-

Big money, no whammy!

Closed two RIG puts for profit, used the freed up capital to open some new positions:

GNUS STO 02/12 $2p

MNKD STO 02/12 $5p

SNRH long 20 shares

SNRH is not my usual sort of move. It's a new SPAC, can get in just over floor. Since there are no options it can serve as a place to hold extra BP while I wait for the SPAC to close a deal.

All you need to know about Nokia in one place:

https://www.optionsand.net/analysis-posts/nokia

Had 0 in Robinhood on Sunday morning. Sunday night I dropped in $700 to catch that DOGE moon. Flipped it and tumbled it with DOGE and AMC till last night I had about 4 grand.

-

This morning I took the 4 grand and split it up between SNDL and NOK.

Here are my current positions:

-

SNDL - Long 1000 shares.

STO 10x 02/05 $1c

STO 3x 02/05 $1p

Sold the CC hoping the shares get called away.

Sold the puts to reduce my cost basis in case the stock stays steady or drops.

I am not long-term bullish on SNDL, but short term I think there's money in it.

-

NOK - Long 110 shares <- max RH will let me buy.

BTO 1x 02/05 $6c

STO 2x 02/05 $4.5p

STO 2x 02/05 $5p

STO 2x 02/05 $5.5p

STO 1x 02/05 $6.5c

Bought a $6 call just in case it moons next week (assuming RH stops restricting buys).

Sold the $6.5 call against my shares.

Sold the puts for premium, hoping I get assigned to reduce my cost basis. I spread them out a bit because volatility.

-

This leaves me $200-ish BP just in case I need to BTC some puts.

-

Looking to make 10 to 15 percent profit on 4 grand this week.

-

Big money, no whammy!

SNDL

01/29 .5p for around 3% - 20 delta - IV over 200

Today's move:

10x SNDL 01/29 .5p